

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.42409640 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.42409640 |
| 3 | myelination (GO:0042552) | 5.95359699 |
| 4 | ensheathment of neurons (GO:0007272) | 5.88246922 |
| 5 | axon ensheathment (GO:0008366) | 5.88246922 |
| 6 | myelin maintenance (GO:0043217) | 5.12408452 |
| 7 | astrocyte development (GO:0014002) | 4.83352660 |
| 8 | L-amino acid import (GO:0043092) | 4.82790489 |
| 9 | fatty acid elongation (GO:0030497) | 4.77063575 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.72110116 |
| 11 | oligodendrocyte differentiation (GO:0048709) | 4.54059455 |
| 12 | response to peptidoglycan (GO:0032494) | 4.52903886 |
| 13 | negative regulation of protein localization to cell surface (GO:2000009) | 4.52455317 |
| 14 | myelination in peripheral nervous system (GO:0022011) | 4.40753585 |
| 15 | peripheral nervous system axon ensheathment (GO:0032292) | 4.40753585 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 4.33448725 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.33333678 |
| 18 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.26541376 |
| 19 | gonadal mesoderm development (GO:0007506) | 4.20619344 |
| 20 | adhesion of symbiont to host cell (GO:0044650) | 4.14567784 |
| 21 | virion attachment to host cell (GO:0019062) | 4.14567784 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.11309581 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.08319282 |
| 24 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.03672805 |
| 25 | amino acid import (GO:0043090) | 4.02983018 |
| 26 | cellular extravasation (GO:0045123) | 3.95856587 |
| 27 | positive regulation of mast cell degranulation (GO:0043306) | 3.94699838 |
| 28 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.94699838 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.84038253 |
| 30 | neutrophil activation (GO:0042119) | 3.79079304 |
| 31 | response to lipoprotein particle (GO:0055094) | 3.78993306 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.73481140 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 3.71923150 |
| 34 | granulocyte activation (GO:0036230) | 3.71665155 |
| 35 | dermatan sulfate biosynthetic process (GO:0030208) | 3.70912548 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.70491885 |
| 37 | adenosine receptor signaling pathway (GO:0001973) | 3.68211395 |
| 38 | detection of other organism (GO:0098543) | 3.60341089 |
| 39 | dermatan sulfate metabolic process (GO:0030205) | 3.59729805 |
| 40 | regulation of collateral sprouting (GO:0048670) | 3.59116219 |
| 41 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.58157204 |
| 42 | cholesterol biosynthetic process (GO:0006695) | 3.54989096 |
| 43 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.54313798 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.54181169 |
| 45 | positive regulation of leukocyte degranulation (GO:0043302) | 3.54098281 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.53006622 |
| 47 | glycosylceramide metabolic process (GO:0006677) | 3.45206616 |
| 48 | regulation of mast cell activation (GO:0033003) | 3.44424698 |
| 49 | negative regulation of neurotransmitter transport (GO:0051589) | 3.41787339 |
| 50 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.41018759 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.40080418 |
| 52 | regulation of platelet activation (GO:0010543) | 3.36517393 |
| 53 | adhesion of symbiont to host (GO:0044406) | 3.35625017 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33802247 |
| 55 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.27057149 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.25579987 |
| 57 | import into cell (GO:0098657) | 3.25505492 |
| 58 | macrophage activation (GO:0042116) | 3.24467506 |
| 59 | photoreceptor cell differentiation (GO:0046530) | 3.22618119 |
| 60 | eye photoreceptor cell differentiation (GO:0001754) | 3.22618119 |
| 61 | barbed-end actin filament capping (GO:0051016) | 3.21551922 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17459924 |
| 63 | regulation of platelet aggregation (GO:0090330) | 3.17214897 |
| 64 | amyloid precursor protein catabolic process (GO:0042987) | 3.16910170 |
| 65 | positive regulation of receptor recycling (GO:0001921) | 3.16255421 |
| 66 | positive regulation of actin filament depolymerization (GO:0030836) | 3.14844404 |
| 67 | presynaptic membrane organization (GO:0097090) | 3.14625927 |
| 68 | asymmetric protein localization (GO:0008105) | 3.13147412 |
| 69 | substantia nigra development (GO:0021762) | 3.12466296 |
| 70 | glial cell development (GO:0021782) | 3.09871083 |
| 71 | glycosphingolipid catabolic process (GO:0046479) | 3.09430140 |
| 72 | sterol biosynthetic process (GO:0016126) | 3.09023166 |
| 73 | detection of bacterium (GO:0016045) | 3.07699801 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06341085 |
| 75 | detection of biotic stimulus (GO:0009595) | 3.05471340 |
| 76 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.04372410 |
| 77 | negative regulation of interleukin-17 production (GO:0032700) | 3.03785245 |
| 78 | immunoglobulin mediated immune response (GO:0016064) | 3.00415031 |
| 79 | amyloid precursor protein metabolic process (GO:0042982) | 3.00076548 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 2.98661750 |
| 81 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.97452757 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96057344 |
| 83 | response to host immune response (GO:0052572) | 2.96057344 |
| 84 | membrane invagination (GO:0010324) | 2.96001734 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95714949 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93851526 |
| 87 | lens fiber cell development (GO:0070307) | 2.91837510 |
| 88 | membrane protein ectodomain proteolysis (GO:0006509) | 2.91328369 |
| 89 | isoprenoid biosynthetic process (GO:0008299) | 2.91028660 |
| 90 | apical protein localization (GO:0045176) | 2.90782081 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88448645 |
| 92 | protein localization to endosome (GO:0036010) | 2.87356434 |
| 93 | positive regulation of osteoblast proliferation (GO:0033690) | 2.85909460 |
| 94 | mannosylation (GO:0097502) | 2.85574450 |
| 95 | chondroitin sulfate catabolic process (GO:0030207) | 2.83906902 |
| 96 | negative regulation of axonogenesis (GO:0050771) | 2.82953448 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.81963422 |
| 98 | negative regulation of cell killing (GO:0031342) | 2.81304967 |
| 99 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81304967 |
| 100 | neuroblast proliferation (GO:0007405) | 2.80129292 |
| 101 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79934682 |
| 102 | creatine metabolic process (GO:0006600) | 2.78895565 |
| 103 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.76265195 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.74076100 |
| 105 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73959210 |
| 106 | phagocytosis, engulfment (GO:0006911) | 2.72558780 |
| 107 | limb bud formation (GO:0060174) | 2.72116215 |
| 108 | regulation of regulated secretory pathway (GO:1903305) | 2.72103248 |
| 109 | glycolipid catabolic process (GO:0019377) | 2.71989759 |
| 110 | negative regulation of myoblast differentiation (GO:0045662) | 2.71330115 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69392611 |
| 112 | response to hepatocyte growth factor (GO:0035728) | 2.69175070 |
| 113 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.69175070 |
| 114 | response to host (GO:0075136) | 2.68460242 |
| 115 | response to host defenses (GO:0052200) | 2.68460242 |
| 116 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68460242 |
| 117 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.68021819 |
| 118 | cortical actin cytoskeleton organization (GO:0030866) | 2.67416653 |
| 119 | positive regulation of gliogenesis (GO:0014015) | 2.66936444 |
| 120 | negative regulation of mast cell activation (GO:0033004) | 2.63583732 |
| 121 | amino sugar catabolic process (GO:0046348) | 2.63207268 |
| 122 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63011222 |
| 123 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.61481435 |
| 124 | positive regulation of macrophage differentiation (GO:0045651) | 2.60669609 |
| 125 | fibril organization (GO:0097435) | 2.60489973 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60133552 |
| 127 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.58692201 |
| 128 | response to muramyl dipeptide (GO:0032495) | 2.57989240 |
| 129 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.57875111 |
| 130 | extracellular matrix assembly (GO:0085029) | 2.57701367 |
| 131 | lipoxygenase pathway (GO:0019372) | 2.57331220 |
| 132 | positive regulation of regulated secretory pathway (GO:1903307) | 2.56855778 |
| 133 | myelin assembly (GO:0032288) | 2.56645668 |
| 134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56344264 |
| 135 | extracellular fibril organization (GO:0043206) | 2.56117444 |
| 136 | glycerophospholipid catabolic process (GO:0046475) | 2.56096503 |
| 137 | neurotransmitter uptake (GO:0001504) | 2.55216872 |
| 138 | T-helper 1 type immune response (GO:0042088) | 2.54918055 |
| 139 | positive regulation of chemokine secretion (GO:0090197) | 2.53820208 |
| 140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.53762023 |
| 141 | negative regulation of axon extension (GO:0030517) | 2.53564408 |
| 142 | membrane raft organization (GO:0031579) | 2.53044382 |
| 143 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.52744874 |
| 144 | response to thyroid hormone (GO:0097066) | 2.52560005 |
| 145 | neutrophil chemotaxis (GO:0030593) | 2.51797757 |
| 146 | regulation of type 2 immune response (GO:0002828) | 2.51302408 |
| 147 | negative regulation of platelet activation (GO:0010544) | 2.50833968 |
| 148 | regulation of beta-amyloid formation (GO:1902003) | 2.50155925 |
| 149 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49366278 |
| 150 | positive regulation of glial cell differentiation (GO:0045687) | 2.49271904 |
| 151 | peptide catabolic process (GO:0043171) | 2.49076590 |
| 152 | glial cell differentiation (GO:0010001) | 2.48648670 |
| 153 | response to redox state (GO:0051775) | 2.48506478 |
| 154 | cortical cytoskeleton organization (GO:0030865) | 2.47851354 |
| 155 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.46159286 |
| 156 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.46154693 |
| 157 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.45727757 |
| 158 | Rap protein signal transduction (GO:0032486) | 2.45210372 |
| 159 | membrane assembly (GO:0071709) | 2.45161223 |
| 160 | platelet aggregation (GO:0070527) | 2.44600416 |
| 161 | neutrophil migration (GO:1990266) | 2.44344790 |
| 162 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.43959185 |
| 163 | establishment of mitochondrion localization (GO:0051654) | 2.43842743 |
| 164 | regulation of mononuclear cell migration (GO:0071675) | 2.42218441 |
| 165 | positive regulation of pseudopodium assembly (GO:0031274) | 2.40182838 |
| 166 | regulation of macrophage cytokine production (GO:0010935) | 2.39383374 |
| 167 | microglial cell activation (GO:0001774) | 2.39007463 |
| 168 | estrogen biosynthetic process (GO:0006703) | 2.37826815 |
| 169 | nucleotide transmembrane transport (GO:1901679) | 2.33674115 |
| 170 | negative regulation of leukocyte migration (GO:0002686) | 2.33231989 |
| 171 | regulation of osteoblast proliferation (GO:0033688) | 2.32823317 |
| 172 | Leydig cell differentiation (GO:0033327) | 2.32096597 |
| 173 | negative regulation of exocytosis (GO:0045920) | 2.30316708 |
| 174 | actin filament depolymerization (GO:0030042) | 2.29746611 |
| 175 | neuron cell-cell adhesion (GO:0007158) | 2.29694125 |
| 176 | enteric nervous system development (GO:0048484) | 2.29228407 |
| 177 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.28716193 |
| 178 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.26334358 |
| 179 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.25879462 |
| 180 | positive regulation by symbiont of host defense response (GO:0052509) | 2.25878082 |
| 181 | modulation by symbiont of host defense response (GO:0052031) | 2.25878082 |
| 182 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.25878082 |
| 183 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.25878082 |
| 184 | modulation by symbiont of host immune response (GO:0052553) | 2.25878082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.55070178 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.30886927 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.28405508 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.06413763 |
| 5 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00322157 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98742841 |
| 7 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.94832313 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94171871 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77110331 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.63576270 |
| 11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.57608202 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.56614167 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48994251 |
| 14 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.42582616 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33226943 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31476598 |
| 17 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.26491344 |
| 18 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.26491344 |
| 19 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.11755824 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07320448 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07253367 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04351514 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98957082 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98309449 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97516712 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97166506 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93288746 |
| 28 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.87991896 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87112994 |
| 30 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85469090 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77061836 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76988028 |
| 33 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.76179032 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75853556 |
| 35 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75506860 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.74495781 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70806209 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65777703 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65406255 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65406255 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65388745 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63979511 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63214298 |
| 44 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.63128220 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60860085 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60775763 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60445890 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59491824 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59348688 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58891716 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58885600 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58758756 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56665695 |
| 54 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56365055 |
| 55 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56315142 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55876079 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54471244 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53870941 |
| 59 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.53462068 |
| 60 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53301913 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52737645 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51352323 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50234593 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50157216 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48877190 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48583774 |
| 67 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47748563 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47309709 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45309853 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42452133 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41739835 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41217482 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39562827 |
| 74 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39214145 |
| 75 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38350270 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38149138 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38058501 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37250681 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35980451 |
| 80 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35728164 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35713787 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32192247 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29730489 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29228127 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28534213 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28290249 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24508097 |
| 88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24156152 |
| 89 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23667624 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23516196 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23056828 |
| 92 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22835301 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21223831 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21121869 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21038716 |
| 96 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21014197 |
| 97 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.20671676 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18857482 |
| 99 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17272923 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16841577 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14968211 |
| 102 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14396515 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11808854 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11023894 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09468547 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09398016 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09031616 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09017902 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08551445 |
| 110 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07881465 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07299223 |
| 112 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06924843 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05942739 |
| 114 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05801569 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05614478 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05462686 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05417319 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05195475 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05034412 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04365951 |
| 121 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.02806844 |
| 122 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02610258 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02113209 |
| 124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01523209 |
| 125 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01103604 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00559186 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00490139 |
| 128 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99189477 |
| 129 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98656849 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97465070 |
| 131 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.96819919 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96554095 |
| 133 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96495480 |
| 134 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95580368 |
| 135 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94843391 |
| 136 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94828958 |
| 137 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94643599 |
| 138 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94372894 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94093879 |
| 140 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93567616 |
| 141 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92788522 |
| 142 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91403365 |
| 143 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90682612 |
| 144 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90135551 |
| 145 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89385823 |
| 146 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89002917 |
| 147 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88398488 |
| 148 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88363190 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88326822 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88279277 |
| 151 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.88104660 |
| 152 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87982106 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87808687 |
| 154 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87244771 |
| 155 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87040223 |
| 156 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87023787 |
| 157 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86340079 |
| 158 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85828910 |
| 159 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85550600 |
| 160 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.85382520 |
| 161 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84794304 |
| 162 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81824871 |
| 163 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79252171 |
| 164 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79252171 |
| 165 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.78493675 |
| 166 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77867360 |
| 167 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77321650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.72754015 |
| 2 | MP0000920_abnormal_myelination | 4.57246548 |
| 3 | MP0005171_absent_coat_pigmentation | 3.99155256 |
| 4 | MP0003303_peritoneal_inflammation | 3.91511476 |
| 5 | MP0003690_abnormal_glial_cell | 3.84918027 |
| 6 | MP0003724_increased_susceptibility_to | 3.84448933 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.68569559 |
| 8 | MP0003136_yellow_coat_color | 3.15104568 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.13721531 |
| 10 | MP0001958_emphysema | 3.05580267 |
| 11 | MP0003436_decreased_susceptibility_to | 2.91087561 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.80192243 |
| 13 | MP0003634_abnormal_glial_cell | 2.77035296 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.60069227 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.57597339 |
| 16 | MP0008004_abnormal_stomach_pH | 2.51806231 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.27754348 |
| 18 | MP0003279_aneurysm | 2.24864245 |
| 19 | MP0004885_abnormal_endolymph | 2.19763895 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.10486200 |
| 21 | MP0004134_abnormal_chest_morphology | 2.06981016 |
| 22 | MP0003828_pulmonary_edema | 2.01249312 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.97699783 |
| 24 | MP0006054_spinal_hemorrhage | 1.96973828 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.95021459 |
| 26 | MP0003632_abnormal_nervous_system | 1.92827586 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.92470990 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.91979646 |
| 29 | MP0000778_abnormal_nervous_system | 1.90200266 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.89973168 |
| 31 | MP0009764_decreased_sensitivity_to | 1.88398414 |
| 32 | MP0002295_abnormal_pulmonary_circulatio | 1.88343998 |
| 33 | MP0004510_myositis | 1.88272144 |
| 34 | MP0003329_amyloid_beta_deposits | 1.86314599 |
| 35 | MP0009785_altered_susceptibility_to | 1.84184755 |
| 36 | MP0005409_darkened_coat_color | 1.82901121 |
| 37 | MP0005025_abnormal_response_to | 1.81215232 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.74294824 |
| 39 | MP0004272_abnormal_basement_membrane | 1.73705290 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.69106197 |
| 41 | MP0001790_abnormal_immune_system | 1.68423486 |
| 42 | MP0005387_immune_system_phenotype | 1.68423486 |
| 43 | MP0004742_abnormal_vestibular_system | 1.68063408 |
| 44 | MP0001299_abnormal_eye_distance/ | 1.66152759 |
| 45 | MP0005671_abnormal_response_to | 1.64268892 |
| 46 | MP0000604_amyloidosis | 1.58683503 |
| 47 | MP0001905_abnormal_dopamine_level | 1.56415619 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.54394148 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.54394148 |
| 50 | MP0000685_abnormal_immune_system | 1.54112911 |
| 51 | MP0004858_abnormal_nervous_system | 1.53940465 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.51637378 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.51344082 |
| 54 | MP0002723_abnormal_immune_serum | 1.51178602 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.49920944 |
| 56 | MP0009840_abnormal_foam_cell | 1.49243405 |
| 57 | MP0000858_altered_metastatic_potential | 1.49029848 |
| 58 | MP0001853_heart_inflammation | 1.47552313 |
| 59 | MP0004947_skin_inflammation | 1.44791852 |
| 60 | MP0001529_abnormal_vocalization | 1.35645267 |
| 61 | MP0009250_abnormal_appendicular_skeleto | 1.35489111 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.35000015 |
| 63 | MP0001819_abnormal_immune_cell | 1.34556083 |
| 64 | MP0001800_abnormal_humoral_immune | 1.34443915 |
| 65 | MP0005388_respiratory_system_phenotype | 1.34153286 |
| 66 | MP0002133_abnormal_respiratory_system | 1.34153286 |
| 67 | MP0003091_abnormal_cell_migration | 1.32903320 |
| 68 | MP0005166_decreased_susceptibility_to | 1.32698029 |
| 69 | MP0001177_atelectasis | 1.31442451 |
| 70 | MP0004883_abnormal_blood_vessel | 1.30139123 |
| 71 | MP0000383_abnormal_hair_follicle | 1.29487149 |
| 72 | MP0005275_abnormal_skin_tensile | 1.29033678 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.27956120 |
| 74 | MP0005023_abnormal_wound_healing | 1.27626180 |
| 75 | MP0005164_abnormal_response_to | 1.27303743 |
| 76 | MP0001486_abnormal_startle_reflex | 1.25902001 |
| 77 | MP0004270_analgesia | 1.24020051 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.23168348 |
| 79 | MP0002419_abnormal_innate_immunity | 1.21551644 |
| 80 | MP0000343_altered_response_to | 1.21353738 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.20887764 |
| 82 | MP0000249_abnormal_blood_vessel | 1.18781278 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.13993407 |
| 84 | MP0003075_altered_response_to | 1.13262145 |
| 85 | MP0002405_respiratory_system_inflammati | 1.10143223 |
| 86 | MP0005165_increased_susceptibility_to | 1.10054145 |
| 87 | MP0004142_abnormal_muscle_tone | 1.07383537 |
| 88 | MP0005508_abnormal_skeleton_morphology | 1.06878371 |
| 89 | MP0003631_nervous_system_phenotype | 1.05280240 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 1.03814388 |
| 91 | MP0002064_seizures | 1.02760204 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.01306596 |
| 93 | MP0010678_abnormal_skin_adnexa | 1.01179636 |
| 94 | MP0000428_abnormal_craniofacial_morphol | 1.00781140 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.98947439 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.98704906 |
| 97 | MP0008469_abnormal_protein_level | 0.98144458 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.97211549 |
| 99 | MP0008874_decreased_physiological_sensi | 0.93997044 |
| 100 | MP0002272_abnormal_nervous_system | 0.91856394 |
| 101 | MP0004859_abnormal_synaptic_plasticity | 0.91638759 |
| 102 | MP0001849_ear_inflammation | 0.90982724 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.90509293 |
| 104 | MP0003880_abnormal_central_pattern | 0.90493240 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.89128436 |
| 106 | MP0002933_joint_inflammation | 0.88469415 |
| 107 | MP0009763_increased_sensitivity_to | 0.88085804 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.87550256 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.87480315 |
| 110 | MP0000733_abnormal_muscle_development | 0.87195149 |
| 111 | MP0001542_abnormal_bone_strength | 0.86933594 |
| 112 | MP0002229_neurodegeneration | 0.86650583 |
| 113 | MP0000716_abnormal_immune_system | 0.86227698 |
| 114 | MP0005410_abnormal_fertilization | 0.85858116 |
| 115 | MP0000749_muscle_degeneration | 0.83341389 |
| 116 | MP0001851_eye_inflammation | 0.82938384 |
| 117 | MP0005390_skeleton_phenotype | 0.82401485 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.80459048 |
| 119 | MP0000955_abnormal_spinal_cord | 0.80153703 |
| 120 | MP0002882_abnormal_neuron_morphology | 0.79372094 |
| 121 | MP0000566_synostosis | 0.78228722 |
| 122 | MP0002398_abnormal_bone_marrow | 0.77198261 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.77110677 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.75654792 |
| 125 | MP0005310_abnormal_salivary_gland | 0.74146176 |
| 126 | MP0001915_intracranial_hemorrhage | 0.72374791 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.70427526 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.69814040 |
| 129 | MP0002090_abnormal_vision | 0.69737933 |
| 130 | MP0002429_abnormal_blood_cell | 0.69155772 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.69134247 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.68563003 |
| 133 | MP0002938_white_spotting | 0.68269429 |
| 134 | MP0003448_altered_tumor_morphology | 0.67710741 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.66670538 |
| 136 | MP0003633_abnormal_nervous_system | 0.66595059 |
| 137 | MP0005257_abnormal_intraocular_pressure | 0.66421201 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.66410569 |
| 139 | MP0000647_abnormal_sebaceous_gland | 0.65573422 |
| 140 | MP0001879_abnormal_lymphatic_vessel | 0.64738332 |
| 141 | MP0003385_abnormal_body_wall | 0.64009035 |
| 142 | MP0000026_abnormal_inner_ear | 0.63345647 |
| 143 | MP0008260_abnormal_autophagy | 0.63289661 |
| 144 | MP0009278_abnormal_bone_marrow | 0.63275427 |
| 145 | MP0000681_abnormal_thyroid_gland | 0.62022889 |
| 146 | MP0000762_abnormal_tongue_morphology | 0.60884176 |
| 147 | MP0010352_gastrointestinal_tract_polyps | 0.59513564 |
| 148 | MP0008569_lethality_at_weaning | 0.58912477 |
| 149 | MP0002115_abnormal_skeleton_extremities | 0.58439874 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.58296150 |
| 151 | MP0005408_hypopigmentation | 0.58069888 |
| 152 | MP0005451_abnormal_body_composition | 0.58010361 |
| 153 | MP0000462_abnormal_digestive_system | 0.56950855 |
| 154 | MP0001663_abnormal_digestive_system | 0.56716046 |
| 155 | MP0004130_abnormal_muscle_cell | 0.56116309 |
| 156 | MP0002066_abnormal_motor_capabilities/c | 0.55836582 |
| 157 | MP0006082_CNS_inflammation | 0.55555244 |
| 158 | MP0005646_abnormal_pituitary_gland | 0.55537963 |
| 159 | MP0002152_abnormal_brain_morphology | 0.55491325 |
| 160 | MP0000767_abnormal_smooth_muscle | 0.55450819 |
| 161 | MP0003795_abnormal_bone_structure | 0.54999789 |
| 162 | MP0002736_abnormal_nociception_after | 0.54913177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.55983231 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.55983231 |
| 3 | Purpura (HP:0000979) | 4.48477462 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.41681182 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.35941892 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.35414110 |
| 7 | Petechiae (HP:0000967) | 4.27419679 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.24335968 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.00791491 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.86124149 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.85988278 |
| 12 | Abnormal platelet volume (HP:0011876) | 3.71104367 |
| 13 | Spontaneous hematomas (HP:0007420) | 3.67083117 |
| 14 | Increased mean platelet volume (HP:0011877) | 3.64995085 |
| 15 | Vascular tortuosity (HP:0004948) | 3.52322895 |
| 16 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.50075486 |
| 17 | Aplasia of the phalanges of the hand (HP:0009802) | 3.50075486 |
| 18 | Aplasia involving bones of the extremities (HP:0009825) | 3.50075486 |
| 19 | Epistaxis (HP:0000421) | 3.47759917 |
| 20 | Menorrhagia (HP:0000132) | 3.42530883 |
| 21 | Gingival bleeding (HP:0000225) | 3.41727898 |
| 22 | Akinesia (HP:0002304) | 3.38904773 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33547846 |
| 24 | Premature rupture of membranes (HP:0001788) | 3.33407820 |
| 25 | Premature skin wrinkling (HP:0100678) | 3.30577815 |
| 26 | White forelock (HP:0002211) | 3.28806726 |
| 27 | Abnormal auditory evoked potentials (HP:0006958) | 3.23758858 |
| 28 | Loss of speech (HP:0002371) | 3.10410206 |
| 29 | Patchy hypopigmentation of hair (HP:0011365) | 3.10153823 |
| 30 | Abnormality of the corticospinal tract (HP:0002492) | 3.01716374 |
| 31 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.93574565 |
| 32 | Myocardial infarction (HP:0001658) | 2.93316689 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.91226307 |
| 34 | Cerebral hypomyelination (HP:0006808) | 2.84893036 |
| 35 | Disinhibition (HP:0000734) | 2.81111394 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.80010040 |
| 37 | Sensory axonal neuropathy (HP:0003390) | 2.78503551 |
| 38 | Abnormality of dentin (HP:0010299) | 2.73111756 |
| 39 | Clumsiness (HP:0002312) | 2.72430885 |
| 40 | Obstructive lung disease (HP:0006536) | 2.69661470 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69661470 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.61439242 |
| 43 | Parakeratosis (HP:0001036) | 2.59665856 |
| 44 | Peritonitis (HP:0002586) | 2.58337946 |
| 45 | Absent frontal sinuses (HP:0002688) | 2.54503865 |
| 46 | Conjunctival telangiectasia (HP:0000524) | 2.53170142 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50967508 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49133194 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49133194 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49133194 |
| 51 | Mutism (HP:0002300) | 2.47611450 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.46355747 |
| 53 | Onion bulb formation (HP:0003383) | 2.45618484 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.44549294 |
| 55 | Megalencephaly (HP:0001355) | 2.43914498 |
| 56 | Coronal craniosynostosis (HP:0004440) | 2.40778081 |
| 57 | Gingivitis (HP:0000230) | 2.40554329 |
| 58 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.38109159 |
| 59 | Wormian bones (HP:0002645) | 2.37381317 |
| 60 | Recurrent skin infections (HP:0001581) | 2.36772444 |
| 61 | Hepatosplenomegaly (HP:0001433) | 2.35066341 |
| 62 | Pulmonary artery stenosis (HP:0004415) | 2.32863815 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.30496783 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30031031 |
| 65 | Hypoplastic left heart (HP:0004383) | 2.28567741 |
| 66 | Impaired platelet aggregation (HP:0003540) | 2.28488917 |
| 67 | Abnormal platelet function (HP:0011869) | 2.28488917 |
| 68 | Intention tremor (HP:0002080) | 2.28061927 |
| 69 | Follicular hyperkeratosis (HP:0007502) | 2.24519993 |
| 70 | Hypoplasia of the iris (HP:0007676) | 2.23215466 |
| 71 | Nuclear cataract (HP:0100018) | 2.22900393 |
| 72 | Spondylolisthesis (HP:0003302) | 2.22387106 |
| 73 | Retinal dysplasia (HP:0007973) | 2.22111286 |
| 74 | Hemiplegia (HP:0002301) | 2.20175306 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19637073 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.19637073 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.19277771 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19277771 |
| 79 | Broad metatarsal (HP:0001783) | 2.19243153 |
| 80 | Axonal loss (HP:0003447) | 2.18956849 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.18119489 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18097210 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18097210 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18097210 |
| 85 | Arterial tortuosity (HP:0005116) | 2.17547950 |
| 86 | Asymmetry of the thorax (HP:0001555) | 2.16661373 |
| 87 | Absent septum pellucidum (HP:0001331) | 2.16047125 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.15948744 |
| 89 | Stomatitis (HP:0010280) | 2.15885661 |
| 90 | Aortic aneurysm (HP:0004942) | 2.13894893 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.12798204 |
| 92 | Hypoplastic pelvis (HP:0008839) | 2.11510771 |
| 93 | Cellulitis (HP:0100658) | 2.09858638 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.09662674 |
| 95 | Gowers sign (HP:0003391) | 2.09178412 |
| 96 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.09124424 |
| 97 | Mitral stenosis (HP:0001718) | 2.07646825 |
| 98 | Bladder diverticulum (HP:0000015) | 2.06976486 |
| 99 | Mitral regurgitation (HP:0001653) | 2.06617522 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.06439072 |
| 101 | Apathy (HP:0000741) | 2.05849290 |
| 102 | Bruising susceptibility (HP:0000978) | 2.05763910 |
| 103 | Morphological abnormality of the inner ear (HP:0011390) | 2.05573181 |
| 104 | Polycythemia (HP:0001901) | 2.04445011 |
| 105 | Alacrima (HP:0000522) | 2.04120568 |
| 106 | Humeroradial synostosis (HP:0003041) | 2.04016734 |
| 107 | Synostosis involving the elbow (HP:0003938) | 2.04016734 |
| 108 | Diminished motivation (HP:0000745) | 2.03430298 |
| 109 | Urticaria (HP:0001025) | 2.03250501 |
| 110 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.03202758 |
| 111 | Retrobulbar optic neuritis (HP:0100654) | 2.03182979 |
| 112 | Optic neuritis (HP:0100653) | 2.03182979 |
| 113 | Stridor (HP:0010307) | 2.02230813 |
| 114 | Relative macrocephaly (HP:0004482) | 2.00431045 |
| 115 | Aortic dissection (HP:0002647) | 1.99771950 |
| 116 | Buphthalmos (HP:0000557) | 1.99453562 |
| 117 | Shallow orbits (HP:0000586) | 1.98859491 |
| 118 | Diminished movement (HP:0002374) | 1.98343074 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96968323 |
| 120 | Recurrent abscess formation (HP:0002722) | 1.96637646 |
| 121 | Stomach cancer (HP:0012126) | 1.96580540 |
| 122 | Hematochezia (HP:0002573) | 1.96172959 |
| 123 | Glomerulonephritis (HP:0000099) | 1.95599498 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.94875378 |
| 125 | Septo-optic dysplasia (HP:0100842) | 1.94033761 |
| 126 | Amyloidosis (HP:0011034) | 1.91326588 |
| 127 | Hypoplastic heart (HP:0001961) | 1.91081982 |
| 128 | Arterial thrombosis (HP:0004420) | 1.88686575 |
| 129 | Orchitis (HP:0100796) | 1.88486692 |
| 130 | Osteomyelitis (HP:0002754) | 1.85785868 |
| 131 | Abnormality of incisor morphology (HP:0011063) | 1.85645675 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.85256817 |
| 133 | Hemoptysis (HP:0002105) | 1.84854139 |
| 134 | Upper motor neuron abnormality (HP:0002127) | 1.83912664 |
| 135 | Chest pain (HP:0100749) | 1.83482010 |
| 136 | Scapular winging (HP:0003691) | 1.83110736 |
| 137 | Termporal pattern (HP:0011008) | 1.82717896 |
| 138 | Insidious onset (HP:0003587) | 1.82717896 |
| 139 | Episodic fever (HP:0001954) | 1.82358683 |
| 140 | Heterochromia iridis (HP:0001100) | 1.82048018 |
| 141 | Prostate neoplasm (HP:0100787) | 1.81695112 |
| 142 | Ankle clonus (HP:0011448) | 1.81514092 |
| 143 | Vertigo (HP:0002321) | 1.80548899 |
| 144 | Bone pain (HP:0002653) | 1.78275784 |
| 145 | Gastrointestinal infarctions (HP:0005244) | 1.78070929 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.77804579 |
| 147 | Myositis (HP:0100614) | 1.77703573 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 1.76697980 |
| 149 | Lissencephaly (HP:0001339) | 1.75991557 |
| 150 | Thick nail (HP:0001805) | 1.75969675 |
| 151 | Meningitis (HP:0001287) | 1.75575124 |
| 152 | Abnormality of molar morphology (HP:0011070) | 1.75296086 |
| 153 | Abnormality of molar (HP:0011077) | 1.75296086 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.75180794 |
| 155 | Short hallux (HP:0010109) | 1.75055535 |
| 156 | Soft skin (HP:0000977) | 1.74772301 |
| 157 | Pathologic fracture (HP:0002756) | 1.73308377 |
| 158 | Abnormality of the frontal sinuses (HP:0002687) | 1.72603577 |
| 159 | J-shaped sella turcica (HP:0002680) | 1.71676659 |
| 160 | Bell-shaped thorax (HP:0001591) | 1.70825119 |
| 161 | Esophageal atresia (HP:0002032) | 1.70703233 |
| 162 | Diplopia (HP:0000651) | 1.68034183 |
| 163 | Abnormality of binocular vision (HP:0011514) | 1.68034183 |
| 164 | Prolonged neonatal jaundice (HP:0006579) | 1.67686174 |
| 165 | Abnormality of the septum pellucidum (HP:0007375) | 1.67652220 |
| 166 | Dementia (HP:0000726) | 1.67630530 |
| 167 | Syringomyelia (HP:0003396) | 1.67577276 |
| 168 | Spinal cord lesions (HP:0100561) | 1.67577276 |
| 169 | Mucosal telangiectasiae (HP:0100579) | 1.66683648 |
| 170 | Cerebral ischemia (HP:0002637) | 1.66243530 |
| 171 | Increased CSF protein (HP:0002922) | 1.66111951 |
| 172 | Femoral bowing (HP:0002980) | 1.64846903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 5.44703569 |
| 2 | RIPK4 | 4.52114650 |
| 3 | STK39 | 3.76361669 |
| 4 | TNIK | 3.53992472 |
| 5 | EPHB1 | 2.98201738 |
| 6 | LIMK1 | 2.90386584 |
| 7 | OXSR1 | 2.84982190 |
| 8 | BCR | 2.80508838 |
| 9 | CASK | 2.49712127 |
| 10 | TYK2 | 2.47849579 |
| 11 | FGFR2 | 2.44293817 |
| 12 | CSK | 2.40387960 |
| 13 | PKN1 | 2.24599006 |
| 14 | IRAK3 | 2.21402391 |
| 15 | PBK | 2.20137402 |
| 16 | CLK1 | 2.09257869 |
| 17 | MET | 1.97437599 |
| 18 | ROCK2 | 1.96291697 |
| 19 | ZAP70 | 1.82110266 |
| 20 | MAP2K3 | 1.81604256 |
| 21 | NEK6 | 1.81257182 |
| 22 | MAPKAPK5 | 1.71637719 |
| 23 | TGFBR2 | 1.69848321 |
| 24 | JAK1 | 1.67379658 |
| 25 | MAP3K3 | 1.61296092 |
| 26 | MUSK | 1.59316393 |
| 27 | ERBB3 | 1.59073330 |
| 28 | MKNK1 | 1.54800831 |
| 29 | TRPM7 | 1.52639493 |
| 30 | NEK9 | 1.51165044 |
| 31 | IRAK4 | 1.42845947 |
| 32 | TESK1 | 1.41286486 |
| 33 | KSR2 | 1.39907786 |
| 34 | HCK | 1.38808187 |
| 35 | JAK3 | 1.35197304 |
| 36 | BMPR1B | 1.34136460 |
| 37 | ERN1 | 1.31920023 |
| 38 | CSNK1A1L | 1.29937598 |
| 39 | CSNK1G3 | 1.29857946 |
| 40 | UHMK1 | 1.29075864 |
| 41 | KIT | 1.28224312 |
| 42 | JAK2 | 1.27705544 |
| 43 | PAK6 | 1.26793455 |
| 44 | PIK3CG | 1.25884439 |
| 45 | SYK | 1.25164109 |
| 46 | TESK2 | 1.23650485 |
| 47 | TYRO3 | 1.22987191 |
| 48 | NTRK1 | 1.19828713 |
| 49 | EPHA3 | 1.16916301 |
| 50 | PRKD3 | 1.15715149 |
| 51 | BTK | 1.13855643 |
| 52 | SGK494 | 1.13140726 |
| 53 | SGK223 | 1.13140726 |
| 54 | LYN | 1.11297268 |
| 55 | MAPK13 | 1.08426987 |
| 56 | CDK19 | 1.06683172 |
| 57 | IRAK1 | 1.06429098 |
| 58 | KSR1 | 1.04797295 |
| 59 | SIK3 | 1.03771952 |
| 60 | TNK2 | 1.03353737 |
| 61 | PAK3 | 1.00434400 |
| 62 | MARK1 | 1.00227092 |
| 63 | TAOK2 | 1.00126419 |
| 64 | PLK2 | 0.99678692 |
| 65 | MAP3K2 | 0.99323760 |
| 66 | ROCK1 | 0.97134754 |
| 67 | FGR | 0.96475665 |
| 68 | MAP3K6 | 0.95968586 |
| 69 | CSNK1G2 | 0.95918697 |
| 70 | WNK1 | 0.95645621 |
| 71 | MAP3K1 | 0.95220413 |
| 72 | MATK | 0.94387619 |
| 73 | CDK14 | 0.91340880 |
| 74 | NTRK2 | 0.91133234 |
| 75 | TAOK1 | 0.89507481 |
| 76 | RET | 0.89237322 |
| 77 | CDK18 | 0.88572049 |
| 78 | TBK1 | 0.88358213 |
| 79 | GRK7 | 0.87898572 |
| 80 | CDK15 | 0.87321724 |
| 81 | TEC | 0.86438093 |
| 82 | DYRK2 | 0.86226081 |
| 83 | CSNK1G1 | 0.86161257 |
| 84 | DDR2 | 0.85512225 |
| 85 | MOS | 0.85422014 |
| 86 | MAP3K13 | 0.83333610 |
| 87 | MKNK2 | 0.82656804 |
| 88 | CSF1R | 0.81782418 |
| 89 | ILK | 0.81773320 |
| 90 | NTRK3 | 0.81544824 |
| 91 | CDC42BPA | 0.79706329 |
| 92 | RIPK1 | 0.78909583 |
| 93 | PDGFRB | 0.78191855 |
| 94 | BLK | 0.77752249 |
| 95 | ICK | 0.76714249 |
| 96 | YES1 | 0.76002630 |
| 97 | EIF2AK1 | 0.75926677 |
| 98 | PRKCH | 0.75729244 |
| 99 | CDK11A | 0.74869067 |
| 100 | PIK3CA | 0.74728193 |
| 101 | PIM2 | 0.74381090 |
| 102 | IKBKE | 0.73857914 |
| 103 | CAMK2D | 0.73106754 |
| 104 | DMPK | 0.72398959 |
| 105 | RAF1 | 0.71888273 |
| 106 | PDPK1 | 0.71424478 |
| 107 | ARAF | 0.70180051 |
| 108 | FER | 0.69941193 |
| 109 | CAMK2B | 0.69892238 |
| 110 | CAMKK2 | 0.68776678 |
| 111 | SGK3 | 0.68445019 |
| 112 | PRKCE | 0.65134588 |
| 113 | MAP3K5 | 0.65048501 |
| 114 | MAP3K14 | 0.64696236 |
| 115 | GRK6 | 0.63028327 |
| 116 | LRRK2 | 0.62183108 |
| 117 | MYLK | 0.60511989 |
| 118 | PAK2 | 0.59632232 |
| 119 | BMX | 0.58768464 |
| 120 | PDGFRA | 0.58126349 |
| 121 | MAPK12 | 0.56953291 |
| 122 | ERBB4 | 0.56406963 |
| 123 | SGK2 | 0.56005623 |
| 124 | CDK6 | 0.54541310 |
| 125 | MST4 | 0.54316451 |
| 126 | PDK1 | 0.54302135 |
| 127 | LCK | 0.53958646 |
| 128 | IKBKB | 0.53627312 |
| 129 | ABL1 | 0.53193884 |
| 130 | BMPR2 | 0.51755073 |
| 131 | EPHB2 | 0.49644879 |
| 132 | MARK2 | 0.49043806 |
| 133 | CDK5 | 0.48842184 |
| 134 | FYN | 0.48031145 |
| 135 | PRKACB | 0.47515928 |
| 136 | PRKG1 | 0.47114898 |
| 137 | TAOK3 | 0.46838003 |
| 138 | MAPK7 | 0.46769267 |
| 139 | CAMK1G | 0.46562498 |
| 140 | ZAK | 0.46407103 |
| 141 | PAK1 | 0.45342704 |
| 142 | GSK3A | 0.44679357 |
| 143 | PTK2 | 0.44339842 |
| 144 | MAP3K12 | 0.43127387 |
| 145 | ERBB2 | 0.43058511 |
| 146 | WNK4 | 0.42771943 |
| 147 | PRKD1 | 0.40886808 |
| 148 | PRKCQ | 0.40439040 |
| 149 | FES | 0.39600763 |
| 150 | PAK4 | 0.39544938 |
| 151 | PTK2B | 0.38232526 |
| 152 | ABL2 | 0.37041538 |
| 153 | SRC | 0.35874542 |
| 154 | CAMK2G | 0.34657637 |
| 155 | CAMK2A | 0.34201403 |
| 156 | PHKG1 | 0.33884723 |
| 157 | PHKG2 | 0.33884723 |
| 158 | IRAK2 | 0.32971029 |
| 159 | FGFR1 | 0.32852596 |
| 160 | TTN | 0.32101054 |
| 161 | MAPKAPK2 | 0.31555699 |
| 162 | STK10 | 0.30913089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.25106040 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.78426703 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.70392709 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.26220695 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.21048971 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.19611517 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.13057848 |
| 8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.05394986 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.92555416 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.91446143 |
| 11 | Axon guidance_Homo sapiens_hsa04360 | 1.88255737 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81853028 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.77345074 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.73057192 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60414397 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.52967968 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.45620790 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39746583 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.35935004 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35576813 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.34559910 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.33273940 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28361308 |
| 24 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.27214583 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26435703 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25097271 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24430784 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24157774 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24017521 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.23774062 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23182288 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22224516 |
| 33 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.21626405 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.21564983 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.14058528 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13300458 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13286843 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.11501557 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11333860 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.09716578 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.08021924 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07959756 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07863064 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05414517 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04969792 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.04867001 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.04342376 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01957797 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00858331 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99927415 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97822102 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96078790 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92711334 |
| 54 | * Endocytosis_Homo sapiens_hsa04144 | 0.92511841 |
| 55 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.90312082 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88587076 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88137662 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87415711 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87219352 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87059118 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87016249 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86798013 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85242742 |
| 64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84758952 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.84251063 |
| 66 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81943557 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.81577661 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79590350 |
| 69 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79443912 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.78386288 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77983546 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77682487 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76633829 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.74605037 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74515602 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74468430 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73120125 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73117211 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72519551 |
| 80 | Melanoma_Homo sapiens_hsa05218 | 0.72240348 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72142959 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.71400479 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.71387062 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70813540 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70723100 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.70697434 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.70106476 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.69850341 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69475784 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68939723 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68416583 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.67073621 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66174812 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64742579 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64650882 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64222154 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64150189 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64040350 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63697033 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63500241 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61578250 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61566229 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61149227 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.60909734 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60753505 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59962950 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59319437 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56708810 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56564861 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56132258 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55245308 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54673110 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54599359 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54303805 |
| 115 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54277947 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53711759 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53445791 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53120221 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52993531 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52497944 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52187582 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51375612 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51274454 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50790146 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49984523 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48906705 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.48106435 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46965818 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46809533 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.46192794 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43991411 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43016286 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.42770092 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42727725 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.41691633 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41147502 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41050720 |
| 138 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39934711 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38841279 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38175681 |
| 141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36268480 |

